Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00763880 · ClinicalTrials.gov registry record · Phase 4
Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction
A Phase 4 study, sponsored by Rhode Island Hospital.
- Terminated
- Registry status
- Phase 4
- Development phase
- 89
- Enrollment target
NCT00763880 is a Phase 4 study that was terminated before completion, run by Rhode Island Hospital. The registered enrollment target is 89 participants.
The verdict
NCT00763880, a Phase 4 study, was terminated before completion, sponsored by Rhode Island Hospital.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 89 participants
- Enrollment target
Study Summary
The purpose of our study is to determine if the use of a hematoma block together with intravenous sedation and analgesia is an effective means of managing forearm fractures in the Emergency Department. To determine this, we have designed a randomized, double-blind, placebo controlled trial of hematoma block versus saline for the manipulation of forearm fractures under conscious sedation with ketamine and midazolam. Our hypotheses are two-fold: First, the use of a hematoma block together with conscious sedation will allow for improved pain control. Second, the use of a hematoma block together with conscious sedation will allow us to use less sedation, therefore promoting faster recovery from sedation and more efficient patient turnover in the Emergency Department.
Interventions
- DRUG Saline
- DRUG Lidocaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2005-11 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00763880
The ClinicalTrials.gov registry entry for NCT00763880 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 89 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rhode Island Hospital, which has 130 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00763880 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00763880 about?
NCT00763880 is a clinical study titled "Hematoma Block as an Adjunct to Procedural Sedation for Forearm Fracture Reduction". The purpose of our study is to determine if the use of a hematoma block together with intravenous sedation and analgesia is an effective means of managing forearm fractures in the Emergency Department. To determine this, we have designed a randomized, double-blind, placebo controlled trial of hemato...
What is the current status of trial NCT00763880?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 89 participants. The study started on 2005-11. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00763880?
The interventions under investigation include: Saline (DRUG), Lidocaine (DRUG).
Who is sponsoring clinical trial NCT00763880?
This trial is sponsored by Rhode Island Hospital, which has 130 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.